Article ISI
Reumatologia Clinica  (2017)

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis=> Pooled efficacy and safety analyses of Phase 3 and long-term extension studies

Radominski, SC; Cardiel, MH; Citera, G; Goecke, A; Jaller, JJ; Lomonte, ABV; Miranda, P; Velez P, Xibillé; D, Kwok; K, Rojo; R, García